Human evidence - Phase 2 type 2 diabetes (Rosenstock et al., Lancet 2023) Adults with type 2 diabetes, 36 weeks
This is not harmful accumulation but intentional, evidence-based dosing that optimises blood glucose control and appetite regulation
Licensed 503A compounding pharmacies require provider oversight and prescriptions
Each additional amino acid increases synthesis complexity exponentially, not linearly
Second, GLP-1 reduces the release of glucagon, another hormone that usually raises blood sugar levels
In our analysis, the subgroup with continuous lifestyle intervention showed significant weight regain, while the subgroup without the continuous lifestyle intervention did not